Bridging assay development and translational research to define clinically meaningful MRD cutoffs and endpoints

Designing MRD-guided clinical trials to inform treatment decisions, including escalation, consolidation & de-escalation strategies

Addressing turnaround time, cost and implementation challenges to ensure MRD assays can move fri om trials into routine practice